L. Yu. Palmova

L. Yu. Palmova

Auto-generated profile, based on publicly available information

L. Yu. Palmova

Kazan State Medical University

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2023 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
AZA. M. Zakirova
A. M. Zakirova
TMT. B. Moroz
T. B. Moroz
DSD. T. Shayapova
D. T. Shayapova
AKA. G. Kadriev
A. G. Kadriev
LPL. Yu. Palmova
L. Yu. Palmova
DKD. A. Kadriev
D. A. Kadriev
Introduction. Acute respiratory viral infections hold a dominant place in the infectious diseases pattern. There are many drugs that can affect separate arms of the immune response.Aim. To analyze the effectiveness of the systemic use of a combined drug containing interferon-α-2b and a complex immunoglobulin preparation in the treatment of respiratory diseases in frequently ill children.Material and methods. We examined 103 children aged 2-12 years. Upon admission, the children were treated with a combined drug containing interferon a-2b and a complex immunoglobulin preparation (CIP) (Kipferon®) rectally. Children in the control group received standard therapy.Results. Children were admitted to the hospital in the first days of the disease (66.02%), mainly in the moderate form of the disease (96.12%). 81.55% had symptoms of intoxication, catarrhal phenomena and respiratory syndrome. Comparing the time from the onset of the disease when prescribing IFN-α-2b to children, their significantly significant differences were established. Introduction in the early stages of the disease contributes to a faster elimination of all symptoms: fever stopped on average (M ± SD) after 1.76 ± 0.33 and 2.05 ± 0.29 days, respectively, from the moment of admission to the hospital, which was on average 2 days less than in the control group. The transition to a productive cough in the main group occurred on average (M ± SD) after 3.25 ± 0.27 days, in the comparative group - after 5.23 ± 0.31, in the control group - after 8.19 ± 0.42 days. In patients of the main and comparative groups, the length of stay in the hospital was significantly shorter - on average (M ± SD) 8.04 ± 0.81 days than in the control group - 10.56 ± 1.42 days. Hematological parameters returned to normal at an earlier time.Discussion. Rectal route of recombinant IFNi-a2b delivery as suppositories is substantiated with regard to etiopathogenesis and immunology.Conclusion. The article presents the outcomes of the clinical use of Kipferon® as part of the combination therapy and prevention of complications of acute respiratory viral infections in children: reduced duration of intoxication, fever, faster improvement of the auscultatory status of the lungs, improvement of immune status indicators.

3 November 2022 in Лечащий врач
Verified
Journal Article
Closed access
LPL.YU. Palmova
L.YU. Palmova
AZA.R. Zinnatullina
A.R. Zinnatullina
EKE.V. Kulakova
E.V. Kulakova
The modern world constantly presents us with unusual challenges. One of the new trends should include electronic cigarettes and vapes, which are firmly embedded in the ubiquitous environment of young people, including minors. In recent years, reports of cases of lung lesions associated with their use, as well as outbreaks of this new pathology, have become increasingly frequent. The article structures foreign and Russian data concerning a new pathology associated with the use of vaping. Clinical forms from exposure to electronic cigarettes can be represented by both acute lung injury (acute pneumonitis, acute respiratory distress syndrome) and a fibrous process (organizing pneumonia, respiratory bronchiolitis). The difficulties of diagnosis are caused, on the one hand, by an underestimation of the current epidemiological situation associated with vaping, on the other – by the absence of pathognomonic symptoms characteristic of EVALI. Differential diagnosis should include a wide range of diseases. Significant difficulties in verifying vape-associated lesions may occur during the rise in the incidence of influenza and COVID-19, both of which may manifest similarly or even simultaneously with EVALI. Lung damage associated with the use of vapes is essentially a diagnosis of exclusion. Therapeutic approaches are not standardized and are rather scarce. According to the literature, the basis of treatment is respiratory support, pharmacotherapy does not have a broad evidence base. In the domestic general medical practice, one should pay more attention to the collection of anamnesis, especially in young people with respiratory and gastroenterological manifestations, indicating the fact of using vapes during the survey. The focus of primary care physicians and the subsequent implementation of a publicly available diagnostic algorithm will allow for the diagnosis of EVALI in a shorter time. In the future, we will continue to study this pathology and search for more specific manifestations of it.

27 July 2023 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
AZA. M. Zakirova
A. M. Zakirova
DSD. T. Shayapova
D. T. Shayapova
KVKh. M. Vakhitov
Kh. M. Vakhitov
LPL. Yu. Palmova
L. Yu. Palmova
ERE. L. Rashitova
E. L. Rashitova
ХВХ. М. Вахитов
Х. М. Вахитов
The article focuses on the most frequent skin diseases in young children. Atopic/allergic dermatitis is one of the most common diseases in children. Approximately 45% of patients develop their first symptoms within the first 6 months after birth, 60% show the onset of atopic dermatitis during the first year of life and 80-85% at the age of 1 to 5 years. The article also speaks about the issue of allergic contact dermatitis (diaper rash in newborns). The disease represents non-specific inflammatory skin changes in the contact area in infants, the onset of which occurs mostly at the age of 1 to 15 months. The factors responsible for causing these diseases, the pathogenesis of their development and the potential of topical therapy mainly targeted at the reduction of clinical manifestations and frequency of exacerbations, improvement of the quality of life and prevention of infectious complications are considered. As an initial treatment, the authors consider a drug containing methylprednisolone aceponate with ceramides of domestic manufacturing. Its effectiveness and safety in the combination therapy of young children suffering from atopic/allergic and contact dermatitis may be evaluated in clinical practice. Clinical case reports of treatment of children with dermatitis of various etiologies aged from 4.5 months up to 3 years are presented. The outcomes of the use of Komfoderm K in children with AD demonstrated a significant decrease in the severity of inflammation, reduction of the skin lesion area and the intensity of symptoms, decreased need for additional intake of antihistamines and anti-inflammatory drugs, and the ability to achieve stable clinical remission.

13 March 2023 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
AZA. M. Zakirova
A. M. Zakirova
RFR. A. Faizullina
R. A. Faizullina
DSD. Т. Shayapova
D. Т. Shayapova
LPL. Yu. Palmova
L. Yu. Palmova
ERE. L. Rashitova
E. L. Rashitova
RKR. P. Kiselеv
R. P. Kiselеv
Introduction. Malnutrition in children manifests itself in the form of general metabolic disorders and leads to impaired cellular differentiation of tissues. The state of nutritional status is an important success factor in the treatment of any disease, therefore, the development of methodological approaches to optimize the nutritional status of children with protein-energy malnutrition is an urgent task.Aim. To study the efficacy and safety of nutritional support in various conditions accompanied by protein-energy malnutrition in children.Materials and methods. 62 cases were analyzed: including 29 with antibiotic-associated diarrhea, 8 with celiac disease, 14 with gastrointestinal allergy (allergic enteropathy), 11 with hypostature against the background of low gestational age with birth. Age – 1–10 years. All patients were divided into groups identical in age, nosology, gender, duration of the pathological condition, degree of malnutrition. In the main group (31 children), the main treatment included a low-microbial diet, sips, parenteral nutrition with glucose-salt solutions (7–10 days), enteral nutrition. The control group consisted of 31 children, in whose therapy there was no enteral nutrition. Anthropometry, clinical, laboratory and instrumental examination were used to assess the nutritional status.Results and discussion. The main syndromes during treatment are: underweight, loss of appetite, intestinal dyspepsia and malabsorption. Analysis of the diet indicated the monotony of the set of products. The course of nutritional support was 15 days. The survey was conducted on the 1st, 5th, 10th, 15th days of the study. The effect of using enteral nutrition in terms of physical development, clinical and laboratory parameters was more significant in the main group compared to conventional methods of nutrition optimization.Conclusions. The use of enteral nutrition in combination with drug therapy shows more significant effectiveness compared to conventional methods of nutrition optimization.

27 February 2024 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
AZA. M. Zakirova
A. M. Zakirova
TMT. B. Moroz
T. B. Moroz
EPE. M. Pokrovskaya
E. M. Pokrovskaya
RFR. A. Faizullina
R. A. Faizullina
SKS. V. Khaliullina
S. V. Khaliullina
МСМ. Ф. Сабирзянова
М. Ф. Сабирзянова
Introduction. Despite numerous scientific works devoted to the problem of acute respiratory diseases, its relevance does not decrease throughout the world, since serious complications with an unfavorable prognosis are possible.Aim. To evaluate the effectiveness of preventive antiviral therapy in children with recurrent respiratory pathology.Materials and methods. Under observation were 43 children (average age 7.43 ± 3.05 years) with recurrent respiratory pathology, who underwent health treatment in the summer period once for 14 days. The main group consisted of 22 children who were prescribed the antiviral therapy as a monotherapy for prophylactic use. The comparison group included 21 patients who underwent preventive treatment using nasopharyngeal irrigation with local antiseptic chemicals. The observation period was 3 months after prophylactic treatment.Results and discussion. After preventive treatment, the total number of episodes of ARI during the observation period in the main group in relation to the comparison group was according to nosologies: acute pharyngitis (p = 0.0317), exacerbation of chronic tonsillitis (p = 0.0137), acute rhinitis (p = 0.0692), rhinosinusitis (p = 0.0429). In the main group, during the observation period, when episodes of upper respiratory tract diseases occurred, antibacterial drugs were prescribed statistically significantly less frequently (p = 0.0296). After the preventive course, compared with the initial data, there was a decline in the number of cases of upper respiratory tract diseases per child on average per quarter. Thus, in the main group, a more pronounced significant difference was revealed in all nosological forms (acute rhinitis, rhinosinusitis p = 0.0081, acute pharyngitis p = 0.0129, tonsillopharyngitis p = 0.0384). In the comparison group – respectively: p = 0.0426; 0.0387; 0.0439.Conclusions. Carrying out preventive treatment as monotherapy in children with recurrent respiratory pathology demonstrated high effectiveness (86.37%) of the antiviral therapy.

1 January 2021 in Medical Education and Professional Development
Verified
Journal Article
Closed access
KFKazan State Medical University of the Ministry of Health of the Russian Federation
Kazan State Medical University of the Ministry of Health of the Russian Federation
LPL.Yu. Palmova
L.Yu. Palmova
GIG.P. Ischmurzin
G.P. Ischmurzin
РЕАЛИЗАЦИЯ ТЕРАПЕВТИЧЕСКИХ ДИСЦИПЛИН И КЛИНИЧЕСКИХ ПРАКТИК В УСЛОВИЯХ ЭПИДЕМИИ НОВОЙ КОРОНАВИРУСНОЙ ИНФЕКЦИИ